Clinical Trials Logo

Clinical Trial Summary

Study to compare the detection of neoplastic lesions between chromoendoscopy and NBI


Clinical Trial Description

Single-blind (patient) randomized study to compare detection of neoplastic lesions between chromoendoscopy and NBI. Patients with Inflammatory Bowel Disease who are to undergo chromoendoscopy according to usual clinical criteria will be included. The endoscopic procedure is similar to the one usually performed. All patients will undergo colonoscopy according to the usual procedure, with Olympus HQ190 series endoscopes, with the same bowel preparation. During intubation, the faecal remains will be thoroughly washed. Patients will be randomly assigned to one of the two techniques: Chromoendoscopy with 0.1% methylene blue or New generation NBI with Near focus. Biopsies will be taken of all those lesions detected, instead of random biopsies. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04403997
Study type Interventional
Source Hospital Universitario La Paz
Contact Eduardo Martín Arranz, PhD
Phone +34912071350
Email emarranz@salud.madrid.org
Status Recruiting
Phase N/A
Start date October 1, 2019
Completion date February 25, 2022

See also
  Status Clinical Trial Phase
Completed NCT03824418 - The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative Colitis
Recruiting NCT02631798 - Chromocolonoscopy With Food-grade Dyes N/A